Earnings Call · Q1 FY2022·2022-05-05

Q1 22EPS +7.94%·Rev n/aQ4 21EPS -12.50%·Rev n/aQ3 21EPS -3.77%·Rev n/aQ2 21EPS -3.92%·Rev n/a⚠ consensus missing

IOVANCE BIOTHERAPEUTICS, INC. IOVA

Sara Pellegrino — Role not explicitly stated, likely Investor Relations or Communications

Dr. Fred Vogt — Interim President and Chief Executive Officer

Dr. Igor Bilinsky — Chief Operating Officer

Jim Ziegler — Senior Vice President, Commercial

Dr. Friedrich Finckenstein — Role not explicitly stated, likely Senior Executive or Head of Clinical Programs

Dr. Madan Jagasia — Medical Affairs

Jean-Marc Bellemin — Chief Financial Officer

−2.5%1d on move date−1.9% vs SPY3d−7.8%5d−15.4%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IOVA calls or request research access.

More IOVA calls Browse calls Request research access